| 2018 | ASTELLAS PHARMA : Announces Launch of Dafclir® Tablets for the Treatment of Infe.. | PU |
| 2018 | ASTELLAS PHARMA : Gene Therapy Research Institution and Astellas Executes Option.. | PU |
| 2018 | ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares | PU |
| 2018 | ASTELLAS PHARMA : Pfizer and Astellas Amend Clinical Research Protocols for Two .. | PU |
| 2018 | Pfizer, Astellas revise two cancer drug trial protocols to speed up results | RE |
| 2018 | ASTELLAS PHARMA : Approval of Linzess® Tablets 0.25 mg in Japan for Additional I.. | PU |
| 2018 | ASTELLAS PHARMA : Announces Acquisition of Quethera - Acquisition furthers ' com.. | PU |
| 2018 | ASTELLAS PHARMA : Application for Supplemental Indication Filed for Hypercholest.. | PU |
| 2018 | ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares | PU |
| 2018 | ASTELLAS PHARMA : U.S. FDA Approves XTANDI® (enzalutamide) for the Treatment of .. | PU |
| 2018 | ASTELLAS PHARMA : Received Approval for Dafclir® Tablets for the Treatment of In.. | PU |
| 2018 | ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares | PU |
| 2018 | ASTELLAS PHARMA : Results from Pivotal Phase 3 PROSPER Trial of XTANDI® (enzalut.. | PU |
| 2018 | ASTELLAS PHARMA : Named to FTSE4Good Index Series for the Seventh Consecutive Ye.. | PU |
| 2018 | ASTELLAS PHARMA : Announces Launch of XTANDI® Tablets in Japan for the Treatment.. | PU |
| 2018 | ASTELLAS PHARMA : and Seattle Genetics Present at ASCO 2018 on Enfortumab Vedoti.. | PU |
| 2018 | ASTELLAS PHARMA : Announces Personnel Change | PU |
| 2018 | ASTELLAS PHARMA : Oncology C3 Prize® Returns for Third Year with Focus on Improv.. | PU |
| 2018 | ASTELLAS PHARMA : and FibroGen Announce Topline Results from Double-Blind Japan .. | PU |
| 2018 | ASTELLAS PHARMA : Submits Application for Approval of Peficitinib for Rheumatoid.. | PU |
| 2018 | ASTELLAS PHARMA : Announces Acquisition of Own Shares | PU |
| 2018 | ASTELLAS PHARMA : U.S. FDA Grants Priority Review to Astellas' New Drug Applicat.. | PU |
| 2018 | ASTELLAS PHARMA : Reports Financial Results for FY2017 | BU |
| 2018 | ASTELLAS PHARMA INC : Ex-dividend day for final dividend | FA |
| 2018 | ASTELLAS PHARMA : Launches Global Campaign in Collaboration with CNN as Part of .. | PU |
| 2018 | ASTELLAS PHARMA : Acquires Universal Cells, Inc. (pdf 178KB) | PU |
| 2018 | ASTELLAS PHARMA : Partners with Discovery Communications for its Global Branding.. | PU |
| 2018 | ASTELLAS PHARMA : Announce Top-Line Results for Two Phase 3 Trials of Peficitini.. | PU |
| 2018 | ASTELLAS PHARMA : Announces Changes in Management Structure, Global Function, an.. | PU |
| 2018 | ASTELLAS PHARMA : Announces Personnel Changes and Organizational Changes (pdf 30.. | PU |
| 2018 | ASTELLAS PHARMA : Announces Transition to a Company with an Audit & Supervisory .. | PU |
| 2018 | ASTELLAS PHARMA : Announces Acquisition of Own Shares (pdf 119KB) | PU |
| 2018 | ASTELLAS PHARMA : Reports Financial Results for the First Nine Months of FY2017 .. | PU |
| 2018 | ASTELLAS PHARMA : Reports Financial Results for the First Nine Months of FY2017 | BU |
| 2018 | ASTELLAS PHARMA : Completes Acquisition of Mitobridge, Inc. (pdf 242KB) | PU |
| 2018 | ASTELLAS PHARMA : Receives Orphan Designation from the European Commission for G.. | PU |
| 2018 | ASTELLAS PHARMA : and Vical Announce Top-Line Results for Phase 3 Trial of Cytom.. | PU |
| 2018 | ASTELLAS PHARMA : Repatha® SC Injection 420 mg Auto Mini Doser Launched in Japan.. | PU |
| 2018 | ASTELLAS PHARMA : Submits Supplemental New Drug Application for Approval of Addi.. | PU |
| 2018 | ASTELLAS PHARMA : Application for Marketing Approval Submitted for Bispecific CD.. | PU |
| 2017 | ASTELLAS PHARMA : to Present at J.P. Morgan Healthcare Conference (pdf 178KB) | PU |
| 2017 | ASTELLAS PHARMA : Announces First Clinical Data from Phase I Study of Gilteritin.. | PU |
| 2017 | ASTELLAS PHARMA : the Institute of Medical Science of the University of Tokyo, C.. | PU |
| 2017 | ASTELLAS PHARMA : Announces Personnel Change(pdf 155KB) | PU |
| 2017 | ASTELLAS PHARMA : Acquires Mitobridge Under Existing Collaboration(pdf 359KB) | PU |
| 2017 | ASTELLAS PHARMA : Submits a New Drug Application for Gonax® 12-Week Extended-Rel.. | PU |
| 2017 | ASTELLAS PHARMA : to Present New Data Exploring Gilteritinib in Newly Diagnosed .. | PU |
| 2017 | ASTELLAS PHARMA : MSD and Astellas conclude co-promotion agreement in Japan for .. | PU |
| 2017 | ASTELLAS PHARMA : and Seattle Genetics Initiate Phase 1b Trial of Enfortumab Ved.. | PU |
| 2017 | ASTELLAS PHARMA : Notice of Completion of Acquisition of Own Shares (pdf 121KB) | PU |
| 2017 | ASTELLAS PHARMA : Reports First Half FY2017 Financial Results, Revises Fiscal Ye.. | BU |
| 2017 | ASTELLAS PHARMA : Positive Topline Results from First Japan Phase 3 Trial for Ro.. | PU |
| 2017 | ASTELLAS PHARMA : Reports First Half FY2017 Financial Results, Revises Fiscal Ye.. | PU |
| 2017 | ASTELLAS PHARMA : Partners with CNBC for its Global Branding Campaign (pdf 409KB.. | PU |
| 2017 | ASTELLAS PHARMA : Enters into a Screening Collaboration Agreement with MMV to Di.. | PU |
| 2017 | ASTELLAS PHARMA : Extension of Agreement Pertaining to Sale of Telmisartan (Mica.. | PU |
| 2017 | ASTELLAS PHARMA : and Universal Cells, Inc. Announce a Collaboration Utilizing U.. | PU |
| 2017 | ASTELLAS PHARMA : Enters into a New Collaborative Research Agreement with TB All.. | PU |
| 2017 | ASTELLAS PHARMA : U.S. FDA Grants Fast Track Designation to Astellas for Develop.. | PU |
| 2017 | ASTELLAS PHARMA : and Seattle Genetics Initiate Pivotal Trial of Enfortumab Vedo.. | PU |
| 2017 | ASTELLAS PHARMA : Mitsubishi Tanabe Pharma, and Daiichi Sankyo Conduct "JOINUS,".. | PU |
| 2017 | ASTELLAS PHARMA : and TOA EIYO Announce Co-promotion Agreement for Kiklin® Capsu.. | PU |
| 2017 | ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares (pdf 311KB) | PU |
| 2017 | ASTELLAS PHARMA INC : Ex-dividend day for interim dividend | FA |
| 2017 | ASTELLAS PHARMA : U.S. FDA Accepts for Review Astellas' Supplemental New Drug Ap.. | PU |
| 2017 | ASTELLAS PHARMA : Submits Supplemental New Drug Application for Approval of Addi.. | PU |
| 2017 | ASTELLAS PHARMA : Astella Announces Status of Acquisition of Own Shares (pdf 311.. | PU |
| 2017 | ASTELLAS PHARMA : Repatha@ Receives Approval for New 420mg Single-Dose Delivery .. | PU |
| 2017 | ASTELLAS PHARMA : Announces Personnel Changes and Organizational Changes（.. | PU |
| 2017 | ASTELLAS PHARMA : First Patient Dosed in Phase 3 MORPHO Trial Evaluating Gilteri.. | PU |
| 2017 | ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares (pdf 329KB) | PU |
| 2017 | ASTELLAS PHARMA : LTL Pharma Succeeds Marketing Approval for "Nivadil® Tablets",.. | PU |
| 2017 | ASTELLAS PHARMA : Announces Acquisition of Own Shares (pdf 310KB) | PU |
| 2017 | ASTELLAS PHARMA : Reports First Quarter FY2017 Financial Results (pdf 434KB) | PU |
| 2017 | ASTELLAS PHARMA : Reports First Quarter FY2017 Financial Results | BU |
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
Prev.
